Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer
Clinical trial NCT01714765 · COMPLETED
Trial details
- NCT number
- NCT01714765
- Sponsor
- Queen Mary University of London
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2012-10-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.